MRI-guided partial breast radiation in three short treatments
Part of Cancer, Skin clinical trials.
This study tests a faster, targeted type of radiation for early breast cancer, using real-time MRI to help plan and guide treatment. It may help deliver the same cancer-fighting effect while limiting radiation to the rest of the breast.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to safely have an MRI scan for radiation planning.
- After your lumpectomy, your surgeon’s cavity needs to be clearly seen on both CT and MRI scans.
- You must be able to sign consent and follow study treatment visits.
- If you can get pregnant, you must have a negative pregnancy test and use effective non-hormonal birth control during treatment.
- Your breast cancer must fit certain size, margin, and staging limits based on pathology (surgery results).
- You should not have key “not eligible” issues like prior breast radiation, BRCA1/2 mutation, or breast implants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This study compares two different ways of giving radiation to the breast after lumpectomy for early-stage breast cancer. It may help determine which approach controls the cancer well while reducing radiation to surrounding healthy tissue.
This trial tests a one-time radiation treatment given directly to the area where your breast cancer was removed. It aims to reduce the need for multiple radiation sessions and may be an option for certain patients with early-stage breast cancer.
This trial studies using MRI images to help plan and guide radiation therapy after breast-conserving surgery. It may help doctors target the right area more accurately while keeping treatment standard and safe.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a focused radiation treatment before surgery for early-stage breast cancer that is hormone receptor positive and HER2 negative. The goal is to give precise radiation only to the tumor, with the hope of reducing side effects and improving outcomes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.